Log in
Department of Medicinal Chemistry
Scientific profile
- Employees
Pracownicy zakładu
Ryszard Bugno, dr
+48 12 6623320
bugno@if-pan.krakow.pl
room 331Rafał Kurczab, dr hab.
+48 12 6623301kurczab@if-pan.krakow.plroom 326Sabina Podlewska, dr hab.
+48 12 6623301smusz@if-pan.krakow.plroom 326Grzegorz Satała, dr
+48 12 6623301satala@if-pan.krakow.plroom 326Katarzyna Szczepańska, dr
+48 12 6623301k.szczep@if-pan.krakow.plroom 326Adam Hogendorf, dr
+48 792287874ahogen@if-pan.krakow.plroom 331Katarzyna Kaczorowska, dr
+48 12 3343720k.kaczor@if-pan.krakow.plroom CEPHARES CF2.15Janusz Malarz, dr
+48 12 6623254malarzj@if-pan.krakow.plroom Radzikowskiego 176Wojciech Pietruś, dr
pietrus@if-pan.krakow.plDawid Warszycki, dr
+48 12 6623301warszyc@if-pan.krakow.plroom 326Aneta Kozioł
+48 12 6623319koziol@if-pan.krakow.plroom 330Krystyna Nędza
+48 12 6623319nedza@if-pan.krakow.plroom 330Achievements
- Publications
- Grants
Grant
Development of protocol for in silico design of compounds inhibit Ebola virus infection
Dawid Warszycki, PhD
New 9- or 10-arylpiperazinoalkyl substituted pyrimido- or diazepino[2,1- f]purines with partial or full 5-HT(1A) agonistic activity
Pawlowski, M., Katlabi, J., Drabczynska, A., Duszynska, B., Charakchieva-Minol, S., Deren-Wesolek, A., Tatarczynska, E., Chojnacka-Wójcik, E., Mokrosz, M.J., Bojarski, A.J.
DOI: 10.1016/S0223-5234(99)80050-6
On the bioactive conformation of NAN-190 (1) and MP3022 (2), 5-HT(1A) receptor antagonists
Paluchowska, M.H., Mokrosz, M.J., Bojarski, A., Wesołowska, A., Borycz, J., Charakchieva-Minol, S., Chojnacka-Wójcik, E.
DOI: 10.1021/jm991045h
Novel 1,4-benzoxazin-3(4H)-one, 1,2-benzoxazolin-3-one and 1,3- benzoxazolin-2,4-dione arylpiperazine derivatives with different 5-HT(1A) and antagonistic 5-HT(2A) activities
Mokrosz, M.J., Kowalski, P., Kowalska, T., Majka, Z., Duszyńska, B., Bojarski, A.J., Fruziński, A., Karolak-Wojciechowska, J., Wesołowska, A., Kłodzińska, A., Tatarczyńska, E., Chojnacka-Wójcik, E.
DOI: 10.1002/(SICI)1521-4184(199911)332:11<373::AID-ARDP373>3.0.CO;2-L
1,2,3,4-Tetrahydroisoquinoline derivatives: A new class of 5-HT(1A) receptor ligands
Mokrosz, M.J., Bojarski, A.J., Duszyńska, B., Tatarczyńska, E., Kłodzińska, A., Dereń-Wesołek, A., Charakchieva-Minol, S., Chojnacka-Wójcik, E.
DOI: 10.1016/S0968-0896(98)00238-7
Structure-activity relationship studies of CNS agents. Part 33 - Crystal and molecular structure of 4-[omega-(benzotriazolyl)alkyl]-1-(2-methoxyphenyl)piperazines with a different pharmacological activity
Karolak-Wojciechowska, J, Fruzinski, A, Bojarski, AJ, Paluchowska, MH, Mokrosz, MJ
DOI: 10.1002/(SICI)1521-4184(199810)331:10<299::AID-ARDP299>3.3.CO;2-V
Determination of hydrophobicity of some n-alkyl derivatives of 1,2,3,4-tetrahydroisoquinoline by reversed-phase thin-layer chromatography
Kepczynska, E, Bojarski, J, Bojarski, AJ
DOI:
Determination of hydrophobicity of some N-alkyl derivatives of 1,2,3,4-tetrahydroisoquinoline by reversed-phase thin-layer chromatography
Kȩpczyńska, E., Bojarski, J., Bojarski, A.J.
DOI:
Crystal and molecular structure of 4-[ω-(benzotriazolyl)alkyl]1-(2- methoxyphenyl)piperazines with a different pharmacological activity
Karolak-Wojciechowska, J., Fruziński, A., Bojarski, A.J., Paluchowska, M.H., Mokrosz, M.J.
DOI: 10.1002/(SICI)1521-4184(199810)331:10<299::AID-ARDP299>3.0.CO;2-3
Crystal and molecular structure of N-tert-butyl-3[4-(2-methoxyphenyl)-1-piperazinyl]-2-phenylpropanamide dihydrochloride (WAY-100135)
Fruzinski, A, KarolakWojciechowska, J, Mokrosz, MJ, Bojarski, AJ
DOI:
Crystal and molecular structure of N-tert-butyl-3[4-(2-methoxyphenyl)-1-piperazinyl]-2-phenylpropanamide dihydrochloride (WAY-100135)
Fruziński, A., Karolak-Wojciechowska, J., Mokrosz, M.J., Bojarski, A.J.
DOI: